A detailed history of Zurich Insurance Group LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurich Insurance Group LTD holds 52,968 shares of REGN stock, worth $55.7 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
52,968
Previous 32,232 64.33%
Holding current value
$55.7 Million
Previous $28.3 Million 80.09%
% of portfolio
0.48%
Previous 0.29%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $18.7 Million - $20.6 Million
20,736 Added 64.33%
52,968 $51 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $36.5 Million - $41.5 Million
-47,092 Reduced 59.37%
32,232 $28.3 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $54.9 Million - $67 Million
79,324 New
79,324 $65.3 Million
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $3.89 Million - $5.34 Million
-14,187 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $127,979 - $149,006
468 Added 3.41%
14,187 $3.94 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $162,083 - $224,417
541 Added 4.11%
13,719 $4.29 Million
Q1 2019

May 15, 2019

SELL
$372.08 - $439.57 $5.81 Million - $6.87 Million
-15,620 Reduced 54.24%
13,178 $5.41 Million
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $1.84 Million - $2.21 Million
5,471 Added 23.45%
28,798 $10.8 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $26,335 - $30,638
-75 Reduced 0.32%
23,327 $9.43 Million
Q2 2018

Aug 14, 2018

BUY
$284.6 - $344.99 $3.88 Million - $4.7 Million
13,625 Added 139.36%
23,402 $8.07 Million
Q1 2018

May 15, 2018

SELL
$315.82 - $393.78 $455,728 - $568,224
-1,443 Reduced 12.86%
9,777 $3.37 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $494,550 - $648,061
1,379 Added 14.01%
11,220 $4.22 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $4.25 Million - $4.96 Million
9,841
9,841 $4.4 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Zurich Insurance Group LTD Portfolio

Follow Zurich Insurance Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurich Insurance Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Zurich Insurance Group LTD with notifications on news.